Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • PLTR vs GSK✓SelectedUSD · GSKPLTR vs GSK performance historyLatest closeAs of-4.52%11/16
Stock and ETF performance explorer

PLTR vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+711.3%
GSK return
+64.4%
Excess return
+646.8%
Maximum drawdown
-48.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-4.5%-0.1%-4.4%-4.5%
7D-5.2%-1.3%-3.9%-5.3%
30D-13.8%+2.7%-16.5%-13.5%
3M-7.8%+2.7%-10.6%-7.5%
6M+19.7%+3.3%+16.4%+20.3%
YTD-9.8%+6.5%-16.2%-9.6%
1Y-7.8%+10.7%-18.5%-7.6%
3Y+711.3%+64.4%+646.9%+715.8%
All+711.3%+64.4%+646.8%+715.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling